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The early induction of allergy is a complex process involving protective and destructive gene variants,
environmental and nutritional co-factors as well as allergen exposure. Although critical doses,
interactions and susceptible time frames have not been identiﬁed so far, late gestation and early
childhood seem to be important time periods for allergic sensitization.
At least three risk factors can be distinguished based on altered early Th1 lymphocyte development.
First, the number of children with an inborn maturation defect may have increased since the beginning
of the last century, when this condition would otherwise have had a lethal outcome without antibiotics
and other modern health care (survival hypothesis). Second, another group of children in industrialized
countries may have a deﬁcit of environmental Th1 triggers during early life (hygiene hypothesis).
A third factor may also be found predominantly in western societies. The prophylaxis of rickets with
vitamin D has the apparent side effect of suppressing Th1 development (vitamin hypothesis).
Experimental as well as epidemiological studies now provide evidence for the vitamin hypothesis,
which is examined in this paper by a time-course analysis of vitamin D application in Germany. Also
paper studies in Swedish anthroposophic school children, the Tristan da Cunha islanders, and Swiss,
Austrian and Bavarian farmers may be linked to either excessive or absent early vitamin D exposure.
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Hundreds of studies have addressed the rise of allergies in
industrialized countries. Research on risk factors has been
inconclusive, factors associated in one study often failed
conﬁrmation in the next study (Kramer, 1988).
THE TRIPLE T HYPOTHESIS
On a cellular level, it has been recognized that the increase
in allergy might be a failure of the immune system to
develop normal immune regulation, rather than a simple
“Th2skewing”oftheimmuneresponse(Wills-Karp,etal.,
2001). Early T helper cell development seems to be
severely disturbed in atopic children with low secretion of
IFNg(Holtetal.,1992; Warner etal.,1994; Prescottetal.,
1998). Th1 cells down-regulate Th2 cells in some systems.
However, a simple Th1/Th2 paradigm has been
questioned as it became clear that Th1 cells were
themselves pro-inﬂammatory and could exacerbate
allergic disease (Akbari et al., 2003). Both conditions
are not mutually exclusive and may coexist.
Based on the Th1/Th2 paradigm a dual T helper cell
hypothesis of allergy initiation has been suggested
(Wjst, 2004). The ﬁrst line hypothesis comes from
the population history of the last century. The survival of
children with an inborn maturation defect—a genetic
disposition—may have been increased by better health
care since the beginning of the last century, when this
condition would have been lethal (survival hypothesis),
(Varner, 2002; Wjst, 2004). Second, another group of
children may have a deﬁcit of environmental Th1 triggers
during early life, also termed the hygiene hypothesis
(Prescott et al., 2003). Third, prophylaxis of rickets with
fortiﬁcation of food in pregnant women and early vitamin
D supplementation in newborns is an environmental
suppressor of Th1 development (vitamin hypothesis)
(Wjst and Dold, 1999). This paper will provide an update
of the vitamin hypothesis and examine the time course of
vitamin prophylaxis with the temporal relationship of the
allergy epidemic.
The Vitamin Hypothesis
Vitamin D was known to have endocrine effects in
calcium homeostasis until two Science papers in the
eighties showed the existence vitamin receptor also
in peripheral mononuclear monocytes and provided
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1983; Tsoukas et al., 1984). The active metabolite of
vitamin D, 1,25-dihydroxyvitamin D3, regulates the
growth, differentiation and function of a broad range of
cells, while the endocrine action is now seen as the “tip of
the iceberg” (Feldman et al., 1997) where most of the
vitamin D effects are observed on dendritic cells.
Differentiation of dendritic cells is suppressed with
reduced surface marker expression, inhibited IL-12 and
increased IL-10 production. Effects on other co-
stimulatory molecules and apoptosis vary, (Cippitelli,
1998; Mathieu and Adorini, 2002; Adorini, 2003). One
report showed vitamin D to be generally immunosup-
pressive (Pichler et al., 2002), which is in accordance with
the known operation of sunlight. Dendritic cell maturation
appears to be impaired with reduced up-regulation of
CD1a, HLA-DR, CD40, CD80, CD83 and CD86
(Piemonti et al., 2000; Canning et al., 2001; Penna and
Adorini, 2001). Even a direct signaling of vitamin D on
naı ¨ve CD4þ T cells toward Th2 differentiation or
maintenance has been suggested (Cantorna et al., 2000;
Boonstra et al., 2001; Mahon et al., 2003).
Antigen-representing cell derived IL-12 and TNFa
(in concert with Th1 cell-derived IFNg) provide the main
differentiation signals to T helper cells and stimulate the
activity of T cytotoxic and NK cells. Interestingly, all
these major cytokines—IL-12, TNFa and IFNg—are
regulated by vitamin D. IL-12 production is blocked by
vitamin D (Lemire, 1995; D’Ambrosio et al., 1998; Grifﬁn
et al., 2001), and is antagonistic to the LPS action (Na
et al., 1999). This mechanism is not fully understood but it
is known that the p40 gene promoter has an IFNg-
regulatory-factor 1 (IRF-1) binding site (Maruyama et al.,
2003). The reduced capacity of antigen-presenting cells to
produce IL-12 in the perinatal period is in line with
increased postnatal Th2 and diminished Th1 response
(Prescott et al., 2003). In contrast to IL-12, vitamin D
increases TNFa mRNA in bone marrow macrophages in a
dose- and time-dependent manner. It also binds to a
vitamin D responsive element (VDRE) in the upstream
promoter of TNFa (Hakim and Bar-Shavit, 2003).
Consecutively, a lack of TNFa inhibits the development
of allergic rhinitis in mice (Iwasaki et al.,2003), which is
consistent with the observation that high human cord-
blood concentrations of TNFa are associated with a lower
risk of atopy (Macaubas et al., 2003). Finally, vitamin D
elicits an inhibitory action on IFNg gene expression
(Staeva-Vieira and Freedman, 2002). A repressive VDRE
is also known in the IFNg promoter (Cippitelli and
Santoni, 1998). While a negative relationship between
atopy and high IFNg levels could be observed (Macaubas
et al., 2003). Taken together, there are three deﬁnite
molecular pathways that link vitamin D exposure and
allergy development.
Is the vitamin D effect persistent throughout lifetime?
This may be concluded from experiments where immature
dendritic cells maintain their status even after
withdrawal of vitamin D and exhibit blunted responses
to maturing stimuli like LPS (Grifﬁn et al., 2001).
Another mechanism leading to a persistent state may be
seen in the perpetuation of the initial expression of
25-hydroxyvitamin-D3-1-a-hydroxylase in monocyte-
derived dendritic cells (Hewison et al., 2003).
Another important question is whether vitamin D
effects are also observed in vivo or only under
experimental conditions. This could be answered in a
recent animal study (Matheu et al., 2003) where mice
were immunized by intraperitoneal injection of chicken
egg albumin and challenged on day 7 with the same
allergen intranasally. By using another group pre-treated
i.c. with 100ng calcitriol they provoked higher allergen-
speciﬁc IgE (600ng/ml in the treatment group) than in
the control group (450ng/ml, p , 0:05) along with a
cytokine proﬁle typical for a Th2 reaction (Matheu et al.,
2003). Indirect evidence for in vivo effects also comes
from human studies where insulin-dependent diabetes
decreases with early vitamin D supplementation, an effect
also described for multiple sclerosis, rheumatoid arthritis
as well as Lyme arthritis, experimental allergic encepha-
lomyelitis, thyroiditis, psoriasis and lupus nephritis
(Hyppo ¨nen, 1999; Adorini, 2002; Mathieu and Adorini,
2002; Adorini, 2003). The effect on type 1 diabetes seems
to last at least over the ﬁrst 12 months of life (Stene and
Joner, 2003).
So far there are only preliminary observations of
vitamin D and later sensitization in humans. The ﬁrst is
more or less an anecdotal report that relates peanut oil
used for the pharmacological preparation of vitamin D
to peanut sensitization (de Montis et al., 1993). The risk
was remarkably high, with an odds ratio of (OR) of 9.0
(p ¼ 0:003), for the vitamin supplement containing
allergen compared to the supplement without allergen.
A ﬁrst human study has been performed in a Finnish birth
cohort (Hyppo ¨nen, 2001). All births in the two northern-
most provinces of Finland were recorded in 1966.
Mothers reported frequency and dose of vitamin D
supplementation when the infants were 1 year old
(n ¼ 10;366). Prevalence of atopy (OR 1.7, p , 0:001),
hay fever (OR 1.5, p , 0.001) and asthma (OR 1.4,
p ¼ 0:05) at age 31 were all greater in participants with
regular rather than irregular vitamin D supplementation
(Hyppo ¨nen 2004; submitted). In an own observational
birth cohort (LISA, Mu ¨nchen) the odds ratio for
sensitization to any allergen tested at 24 months
was 2.4 (0.6–10.0, Labereau, 2003; pers. comm.) where
only 39 of 1754 children did not report vitamin D
supplementation.
Prophylaxis of Rickets and Rise of Allergy in
Germany
Another important piece in the puzzle is the parallel
increase of rickets and decrease of allergy. In 1923, rickets
were still endemic: “Rickets occurs chieﬂy in Europe and
North America. It is a disease found in cities. It is most
prevalent in those nations whose wealth and industrial
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substitution of artiﬁcial conditions of living in place of
the simple conditions which nature intended. Wherever
civilization of this artiﬁcial character establishes new
contacts, rickets begins to appear... The disease never
occurs among people living under natural conditions.
Savages may starve and may become the victims of
pestilence, but they do not develop rickets. The disease
does not occur in the native parts of Africa...” (Park,
1923). Rickets were consecutively recognized as a
failure of newly formed osteoid to be mineralized,
which is a vitamin D dependent process (Wharton and
Bishop, 2003).
Although ergosterin had been discovered by Adolf
Windaus in Go ¨ttingen (Germany) already in 1926
(awarded with the Nobel prize in chemistry in 1928),
rickets was still a major problem in Germany for the
following decades. In 1935, a dissertation (Riederer von
Paar, 1936) examined 5632 live born children in Munich.
The public welfare recorded that 38% of the children had
signs of rickets. Mainly for costs reasons, prophylaxis was
seldom used: a 10ml Vigantol ﬂask was sold for 1,35
Reichsmark and a complete prophylaxis cost 3,46.
Reichsmark. In 1936, Harnapp at the Charite ´ in Berlin
introduced the “Stosstherapie”, with up to 15mg
D2 (,600IU) (Selle, 1987), which was recommended
in 1939 by the “Reichsministerium des Innern” for
prophylaxis (“Runderlass zur Rachitisprophylaxe”).
A 10mg single dose (Reinisch, 1989) developed as the
prophylactic standard in high risk children born in autumn
or already having a sibpair with rickets. The dose ﬁnding
was “what has been the equivalent of a tablespoon liver
cod oil”, which had been proven safe for the prevention of
rickets (Vieth, 1999).
During World War II vitamin prophylaxis was more or
less discontinued and even in the postwar years vitamin D
supply was difﬁcult. In 1950 the state of Bavaria again
introduced a single dose given by midwives (“Hebam-
menstoss”), which was then adopted also by other federal
States. Around 1950, however, several reports of
hypervitaminosis were published. This led Hermann Mai
(1956),theTu ¨bingenpediatrician,presidentoftheGerman
Society of Pediatrics and frequent visitor of Albert
Schweitzers’s Lambarene (where he never encountered
rickets), to issue a warning on using the standard
prophylactic scheme (“encourage caution”) (Selle,
1987). His recommendation was 5mg baseline vitamin
given, fractionated into 5 single doses, with sufﬁcient
sunlight exposure and carefully control for the early signs
of rickets. In contrast, Harnapp jun. continued with a
4 £ 15mg vitamin dose during the ﬁrst 12 months, a
scheme that was adopted in the centralized medical
system of East Germany(since 7 Oct. 1949) and continued
more or less until the fall of the wall (9 Nov. 1989).
Doses of 15mg (,100,000IU) were given at months 1, 4,
7, 11, 15 and 20; in 1986 ergocalciferol was replaced by
cholecalciferol.
The East German procedure was different from that
in West Germany, where the situation from 1955–1965
was more or less chaotic. Von Giertmu ¨hlen in
Hamburg introduced in 1960, a scheme of daily vitamin
supplementation (von Giertmu ¨hlen, 1962), while
Hellbru ¨g g ei nM u n i c ha n dS i m o ni nO l d e n b u r g
recommended the fortiﬁcation of milk (Reinisch, 1989).
Some doctors treated pregnant women with two vitamin
doses at months 6 and 9 (von Beuren, 1964), others used
stoss therapy of the newborn, as single dose or
fractionated, others prescribed daily vitamin doses from
300 to 5000IU and others did nothing and waited
for the ﬁrst symptoms of rickets. Following reports of
supravalvular aorta stenosis induced by hypervitaminosis,
a press campaign started in West Germany accusing
vitamin D as the culprit (von Beuren, 1964). Rickets
increased again (Selle, 1987). As a consequence more and
more physicians were in favor of daily low doses (Ho ¨vels,
Reiss and others), a scheme that was ﬁnally adopted in
West Germany following a symposium of the Society of
Social Pediatrics 1970 in Karlsruhe, where a dose of
500IU daily was recommended based on a large-scale
study by Wolf and del Solar (1970) and Wolf et al. (1972).
This procedure ﬁnally was adopted in West Germany; as
of 1 July 1971 a central childhood examination program
(Vorsorgeuntersuchung, U1–U6) was established. Rickets
then did not play a major role in Germany: only 100 cases
were observed over ten years in the isolated region of
Berlin from 1978 to 1988, more than one-quarter were of
Turkish nationality (26%) (Reinisch, 1991).
Unfortunately, there are no longitudinal data available
on allergic sensitization that could be directly compared
with the history of rickets prophylaxis. There is one cross-
sectional study, however, that examined a large population
census representative population where historical birth-
cohorts may be constructed. Nicolai (1999) examined two
large samples between 25 and 69 years of age in West
(1991, n ¼ 5313) and East Germany (1992, n ¼ 2617)
with a serological test screening for IgE antibodies to
common aeroallergens. Results may not be over-
interpreted as current sensitization may also depend on
current risk factors (and birth cohorts are only available
for longer time intervals). Nevertheless, a comparison may
give an impression of whether there is any temporal
relationship. At least 3 phases may be deﬁned. In phase 1
cod liver oil was used (Sanostol and other preparations),
with the ﬁrst administration of synthetic vitamin D around
1940. Allergic sensitization is lowest in this cohort
born around 1927, with ,5% sensitized both in East and
West Germany. The 1937 and 1947 East and West cohorts
showed a similar trend in sensitization prevalence of up to
,10%, which is in accordance with the more widespread
use of vitamin D for prophylaxis. Phase 2 is characterized
by a continuous “stoss” application in East Germany
(DDR) from 1949 to 1989 (with a change of vitamin
preparation in 1986) many ups and downs in West
Germany (BRD) where after 1970 all children received
daily vitamin doses. Correspondingly, the sensitization
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below 15%, while only the 1965 cohort showed a minor
increase to ,18%. However, the most signiﬁcant increase
is seen in the West German cohort of 1957 (,23%), which
even goes up to ,27% in the 1965 cohort. Phase 3 may be
deﬁned by the period after the uniﬁcation of Germany
where East German pediatricians abandoned their former
vitamin D stoss therapy in favor of the West German
daily application. The concomittant effect on allergic
sensitization has been documented by many cross-
sectional studies that showed initially much higher rates
in West Germany, where the East German rate
converges now on the VDU level (von Mutius, 1996).
As a summary there seems to be a parallel trend in the
German history of vitamin supplementation and increase
of allergies.
A CAUSAL RELATIONSHIP?
The geographical distribution of allergies has been
reviewed earlier (Wjst and Dold, 1999). Where the
vitamin D supplementation of milk and dairy products in
many English-speaking countries is associated with high
allergy rates (Salle, 2000), it is tempting to speculate that
this dose is also sufﬁcient to have immunological effects
by its active metabolite. Mothers who received sup-
plements during the third trimester had children that were
on an average 400g heavier and 1.6cm longer at 12
months. Interestingly, the vitamin D receptor has been
found in the fetus as early as the 13th week of gestation
(Salle, 2000), while the allergen-speciﬁc response can be
detected around the 22nd week (Jones, 1996).
Elegantly, the vitamin hypothesis also explains some
other observations. It has been predicted that the increase
of allergy in families with high socioeconomic status as
well as the birth order effect may be explained by better
adherence to vitamin prophylaxis recommendations (Wjst
and Dodd, 1999). This could be shown in a Finnish birth
cohort (Hyppo ¨nen 2003; pers. comm.). It has also been
reported that being born abroad is better than being born in
a high allergy country (Smith, 1976). Keeping the
traditional lifestyle could have protected Turkish children
born in Munich around 1980 from getting allergies like
their native Bavarian peers (Kabesch, 1999), as Turkish
immigrants did not come to Munich before 1961. Another
interesting observation relates to the secular decrease of
tuberculosis (Murray, 2004) where epidemiologic analysis
also showed an inverse geographical relationship with
allergy (von Mutius et al., 2000). The vitamin hypothesis
may provide the missing link as vitamin D deﬁciency is
associated with susceptibility to tuberculosis (reviewed in
Davies, 1985).
There are even more recent studies that may be
interpreted in a different way than in their original context.
One example is the Tristan da Cunha study with the
unexpectedly high prevalence of allergy (Slutsky and
Zamel, 1997). The islanders eat and process mainly sea
bass (German Seebarsch or French Loup de Mer,
N. Zamel, 2003; pers. comm.), known to be rich in
vitamin D. The closely related striped bass contains
approximately 1200IU/ml liver oil (Sebrell, 1954).
Another example is the East German margarine
controversy, where margarine use has been associated
with allergy in two studies (von Mutius, 1998; Bolte et al.,
2001). A 20g margarine—the typical daily dose of one
of the few foods supplemented in Germany with vitamin
D—contains between 0 and 56IU (S. Koch, 2003; pers.
comm.) A nutritional supplement as used in the US may
also explain the Boston “milk in crib” phenomenon
(Celedon et al., 2002) and also the recent Perth ﬁsh oil
study of pregnant woman (Dunstan et al., 2003). A lower
allergy prevalence was observed in Swedish anthropo-
sophic schools (Alm et al., 1999), where parents avoid
vitamin D. Finally, the protection of Swiss, Austrian and
Bavarian farm children against allergies (Riedler, 1999)
may be explained by neglected vitamin D supplemen-
tation due to consuming otherwise healthy home grown
food.
Although some of the classical criteria of a causal
relationship are already fulﬁlled, the ﬁnal evidence could
come from a large-scale prospective dose-titrating study
of oral vitamin D supplementation that takes into account
sunlight exposure as well as genetic vitamin sensitivity. It
is an intriguing research question whether genetic
polymorphisms in the metabolism and signaling pathway
of vitamin D are modulating the vitamin response. In any
case, vitamin D exposure is an elaborate factor in the triple
T hypothesis of allergy induction.
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